Please try another search
Fresenius Kabi Oncology Limited researches and develops, manufactures, and markets anti-cancer drugs for critical and chronically ill patients in India and internationally. The company’s products portfolio includes injectables, oral cytotoxics, cytostatics, intermediates, dosage forms, and active pharmaceutical ingredients used in the therapeutic areas of breast cancer, lung cancer, ovarian cancer, head and neck cancer, prostate cancer, hematological malignancies, gastrointestinal malignancies, brain tumors, and supportive care. It also exports its products. Fresenius Kabi Oncology Limited was formerly known as Dabur Pharma Ltd and changed its name to Fresenius Kabi Oncology Limited in 2009. The company was incorporated in 2003 and is based in Gurugram, India. Fresenius Kabi Oncology Limited operates as a subsidiary of Fresenius Kabi (Singapore) Pte Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review